Ionis Pharmaceuticals, Inc.
Modulators of diacyglycerol acyltransferase 2 (DGAT2)

Last updated:

Abstract:

The present embodiments provide methods, compounds, and compositions useful for inhibiting DGAT2 expression, which may be useful for treating, preventing, or ameliorating a disease associated with DGAT2.

Status:
Grant
Type:

Utility

Filling date:

28 Jun 2019

Issue date:

26 Apr 2022